Skip to content

Midkine Role With Deregulated Oxidative and Immune Milieu in Induction of Preeclampsia

Midkine Interplays With Oxidative Stress and Inflammatory Milieu to Induce Preeclampsia in Normotensive Pregnant Women

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06329284
Enrollment
80
Registered
2024-03-25
Start date
2023-01-01
Completion date
2023-12-15
Last updated
2024-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pre-Eclampsia

Brief summary

Preeclampsia (PE) is a hypertensive pregnancy-related disorder that endangers maternal and fetal outcomes and accounts for 9-10% of maternal mortalities with its early-onset phenotype is the most dangerous, but its etiology is still not fully elucidated. Midkine (MDK) is a multifunctional protein that plays a unique role in the development of hypertension (HTN), via its proatherogenic effect and induction of overexpression of angiotensin converting enzyme. Oxidative stress (OS) upregulates the expression of MDK and MDK induces propagation of neoangiogenesis and acts as chemotactic for neutrophils.

Interventions

DIAGNOSTIC_TESTELISA

ELISA estimation of serum Midkine, tumor necrosis factor Alfa, superoxide dismutase, malondialdehyde, placental growth factor and placental soluble fms-like tyrosine kinase 1

Sponsors

Benha University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Intervention model description

Newly pregnant normotensive (NT) women with singleton fetus

Eligibility

Sex/Gender
FEMALE
Age
21 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* Newly pregnant normotensive (NT) women with singleton fetus; * Free of the

Exclusion criteria

.

Design outcomes

Primary

MeasureTime frameDescription
Severity of Pre-Eclampsia (PE)8 monthsCorrelation between Serum midkine levels and blood pressure measurements

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026